Back
Summit Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
54
SMMT
Summit Therapeutics
Last Price:
$24.37
Seasonality Move:
17.66%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMMT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Summit Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.22 | Buy |
| 20-day SMA: | 22.05 | Buy |
| 50-day SMA: | 22.83 | Buy |
| 200-day SMA: | 20.98 | Buy |
| 8-day EMA: | 17.9 | Buy |
| 20-day EMA: | 9.8 | Buy |
| 50-day EMA: | 4.5 | Buy |
| 200-day EMA: | 1.21 | Buy |
Summit Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.19 | Buy |
| Relative Strength Index (14 RSI): | 61.07 | Buy |
| Chaikin Money Flow: | 1683753 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.91 - 23.69) | Buy |
| Bollinger Bands (100): | (18.81 - 25.33) | Buy |
Summit Therapeutics Technical Analysis
| Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Summit Therapeutics Stock
Is Summit Therapeutics Stock a Buy?
-
Summit Therapeutics share price is 25.40 while SMMT 8-day simple moving average is 24.22, which is a Buy signal.
-
The stock price of SMMT is 25.40 while Summit Therapeutics 20-day SMA is 22.05, which makes it a Buy.
-
Summit Therapeutics 50-day simple moving average is 22.83 while SMMT share price is 25.40, making it a Buy technically.
-
SMMT stock price is 25.40 and Summit Therapeutics 200-day simple moving average is 20.98, creating a Buy signal.
SMMT Technical Analysis vs Fundamental Analysis
Buy
54
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy or a Sell?
-
Summit Therapeutics stock is rated a BuyThe current Summit Therapeutics [SMMT] share price is $25.40. The Score for SMMT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
Summit Therapeutics Stock Info
Market Cap:
18.9B
Price in USD:
25.40
Share Volume:
3M
Summit Therapeutics 52-Week Range
52-Week High:
36.91
52-Week Low:
8.39
Buy
54
Summit Therapeutics (SMMT)
is a Buy
Summit Therapeutics Share Price Forecast
-
What is the Summit Therapeutics stock price today?The Summit Therapeutics stock price is 25.40 USD today.
-
Will SMMT stock go up or go down?Summit Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Summit Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Summit Therapeutics is not overvalued.
Is Summit Therapeutics Stock a Buy?
-
Summit Therapeutics share price is 25.40 while SMMT 8-day exponential moving average is 17.90, which is a Buy signal.
-
The stock price of SMMT is 25.40 while Summit Therapeutics 20-day EMA is 9.80, which makes it a Buy.
-
Summit Therapeutics 50-day exponential moving average is 4.50 while SMMT share price is 25.40, making it a Buy technically.
-
SMMT stock price is 25.40 and Summit Therapeutics 200-day simple moving average is 1.21, creating a Buy signal.
Fundamental Analysis of Summit Therapeutics
Is Summit Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.11 per share.
Technical Analysis of Summit Therapeutics
Should I short Summit Therapeutics stock?
-
SMMT Moving Average Covergence Divergence (MACD) indicator is 6.19, suggesting Summit Therapeutics is a Buy
-
Summit Therapeutics Relative Strength Index (RSI) is 61.07, which suggest Summit Therapeutics is overbought
-
The Bollinger Bands (25) for Summit Therapeutics is (19.91 - 23.69), which suggest Summit Therapeutics is a Buy
-
The Bollinger Bands (100) for Summit Therapeutics is (18.81 - 25.33), which suggest Summit Therapeutics is a Buy
* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.